11:00am-12:00pm Eastern Time (US)

Potential New Frontiers in Therapy for Langerhans Cell Histiocytosis
Hosted by the LCH Steering Committee

The LCH Steering Committee is pleased to invite you to our first webinar in this year's series which will include:

    • Presentation of top-ranked LCH abstracts submitted for the Annual Meeting
      • The role of BRAF-mutated hematopoietic cells in patients with Langerhans cell histiocytosis - Sebastian Eder
      • Genetic Landscape and its Prognostic Significance in Children with Langerhans Cell Histiocytosis - Chan-Juan Wang

    • Presentation of publication from Nature Medicine:
      • BRAFV600E-induced senescence drives Langerhans cell histiocytosis pathophysiology - Camille Bigenwald

    We look forward to seeing you online!  

    Please Note: This webinar will be open to and intended for Medical Professionals only.  
    Patients and families are encouraged to connect with the Histiocytosis Association for information on upcoming patient and family-focused webinars.

    About the Society

    The Histiocyte Society is a nonprofit organization of more than 200 physicians and scientists from around the world committed to improving the lives of patients with histiocytic disorders by conducting clinical and laboratory research into the causes and treatment of this disease.

    Copyright © 2020 Histiocyte Society

    Phone: +1 856 589 6606 
    Fax: +1 856 589 6614
    332 N Broadway
    Pitman, NJ 08071 USA

    Powered by Wild Apricot Membership Software